Free Trial

Aardvark Therapeutics (AARD) Earnings Date, Estimates & Call Transcripts

Aardvark Therapeutics logo
$4.20 -0.34 (-7.49%)
As of 05/26/2026 04:00 PM Eastern

Aardvark Therapeutics Earnings Summary

Aardvark Therapeutics released Q1 2026 earnings on May 7, 2026, reporting an EPS of -$0.99. With a trailing EPS of -$3.21, Aardvark Therapeutics' earnings are expected to grow next year, from ($3.46) to ($3.05) per share.

Q1 2026 Earnings Resources

Get Aardvark Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aardvark Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

AARD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Aardvark Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.87-$0.87-$0.87
Q2 20261-$0.95-$0.95-$0.95
Q3 20261-$0.88-$0.88-$0.88
Q4 20261-$0.96-$0.96-$0.96

Aardvark Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026--$0.99--$0.99--
3/23/2026Q4 2025-$0.81-$0.81--$0.81--
11/13/2025Q3 2025-$0.82-$0.75+$0.07-$0.75--
8/13/2025Q2 2025-$0.52-$0.66 -$0.14-$0.66--
5/14/2025--$0.70-$0.71 -$0.01-$0.71--

Data powered by Fiscal.ai.

Aardvark Therapeutics Earnings - Frequently Asked Questions

Aardvark Therapeutics (NASDAQ:AARD) last announced its quarterly earning data on Thursday, May 7, 2026. Learn more on AARD's earnings history.

Aardvark Therapeutics (NASDAQ:AARD) has a recorded net income of -$57.59 million. AARD has generated -$3.21 earnings per share over the last four quarters.

Aardvark Therapeutics' earnings are expected to grow from ($3.46) per share to ($3.05) per share in the next year.


This page (NASDAQ:AARD) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners